Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dextran Products is a specialized biotechnology company and a division of Polydex Pharmaceuticals Limited, focused on the manufacture of high-quality dextran and its derivatives. Based in Toronto, Canada, the company produces a wide range of products including dextran sulfate, iron dextran, and various molecular weight dextrans for pharmaceutical, veterinary, and research use. Their primary commercial product is iron dextran, used extensively in the veterinary industry to treat iron deficiency anemia in piglets. The company operates a GMP-compliant manufacturing facility and supplies bulk ingredients to global pharmaceutical partners. In addition to veterinary products, they provide specialized dextran fractions used in clinical diagnostics and as stabilizers in various medical applications. As a key player in the niche dextran market, the company maintains rigorous quality control standards to meet international pharmacopeia requirements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dextran Products.